Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.84 USD | +0.94% | +5.64% | -12.47% |
Financials (USD)
Sales 2024 * | 316M | Sales 2025 * | 418M | Capitalization | 1.22B |
---|---|---|---|---|---|
Net income 2024 * | -58M | Net income 2025 * | 18M | EV / Sales 2024 * | 2.96 x |
Net cash position 2024 * | 280M | Net cash position 2025 * | 360M | EV / Sales 2025 * | 2.05 x |
P/E ratio 2024 * |
-22.8
x | P/E ratio 2025 * |
70.4
x | Employees | 264 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.28% |
Latest transcript on Mirum Pharmaceuticals, Inc.
1 day | +0.94% | ||
1 week | +5.64% | ||
Current month | +2.91% | ||
1 month | +4.45% | ||
3 months | -2.56% | ||
6 months | -13.87% | ||
Current year | -12.47% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 45 | 18-05-06 | |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Peter Radovich
PSD | President | 46 | 20-04-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Walbert
BRD | Director/Board Member | 57 | 23-04-04 |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Patrick Heron
BRD | Director/Board Member | 53 | 18-11-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 25.84 | +0.94% | 341,067 |
24-05-02 | 25.6 | -0.47% | 313,320 |
24-05-01 | 25.72 | +2.43% | 681,541 |
24-04-30 | 25.11 | +0.16% | 538,614 |
24-04-29 | 25.07 | +2.49% | 369,245 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.47% | 1.22B | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- MIRM Stock